# A Study of Acyclovir to Help Prevent HIV Infection in People With Genital Herpes

> **NCT00076232** · PHASE3 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 3682 (estimated)

## Conditions studied

- HIV Infections
- HIV Seronegativity
- Herpes Genitalis

## Interventions

- **DRUG:** Acyclovir
- **DRUG:** Acyclovir placebo

## Key facts

- **NCT ID:** NCT00076232
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-04
- **Primary completion:** 2007-06
- **Final completion:** 2007-11
- **Target enrollment:** 3682 (ESTIMATED)
- **Last updated:** 2010-12-30

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00076232

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00076232, "A Study of Acyclovir to Help Prevent HIV Infection in People With Genital Herpes". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00076232. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*